Al Nowais stated that the UAE’s healthcare achievements reflect its leadership’s ambitious vision to adopt and develop global advancements in medicine. “For lasting and positive change in human longevity, we must focus on precision, preventive, and predictive medicine,” he explained.
M42, in collaboration with UAE government entities, is reshaping healthcare by transitioning from traditional treatments to a prevention-focused model. This approach prioritizes early disease detection, sustainable healthcare practices, and general well-being.
The integration of artificial intelligence and genomics into healthcare is central to UAE’s progress. Key innovations from M42 include:
M42’s Omics Centre of Excellence is advancing genomic research, particularly through the UAE Genome Programme, aimed at creating proactive health management strategies. This initiative is laying the foundation for precision medicine, where treatments are tailored to individual genetic profiles.
M42 also focuses on promoting healthy ageing and improving life quality through sustainable healthcare systems. These efforts align with the UAE’s broader goal of fostering a resilient and proactive healthcare infrastructure.
Al Nowais concluded by highlighting M42’s commitment to enhancing longevity and advancing global healthcare through innovation, collaboration, and sustainability.
